Medidata dives into Japanese trials; China targets Indian scientists;

> Medidata ($MDSO) is lending its cloud-based technology to a Japanese pharma group, collaborating to calculate the cost of running clinical trials in the country. More

> Chinese research organizations are poaching Indian scientists in hopes of building up their local formulation expertise, according to The Economic Times. News